Main content

Brexit Watch: Public Health After Brexit

What would Brexit mean for collaboration with the European Medicines Agency?

The European Medicines Agency is based in London and is responsible for the safety of medicines developed by pharmaceutical companies for use in the EU. If Article 50 is triggered then the UK will leave the EMA. Dan Damon finds out about the potential impact of this with Professor Sir Michael Rawlins, the chairman of the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK.

(Photo: Medicine, water and a stethoscope. Credit: Franck Fife/AFP)

Available now

14 minutes

More episodes

See all episodes from World Update: Daily Commute

Featured in...

  • Countdown to BrexitNewshour

    News and analysis of events leading to the UK triggering Article 50 and leaving the EU

  • BrexitWatch

    A weekly series looking behind the headlines as Britain prepares to exit the EU

The Global News Podcast

The day's top news stories - find it here or subscribe wherever you find your podcasts

Podcast